Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19022694 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta
Condition: Fabry Disease
Intervention:

Study has passed its completion date and status has not been verified in more than two years.